{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:31:21Z","timestamp":1791228681029,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T00:00:00Z","timestamp":1281571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T00:00:00Z","timestamp":1281571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1038\/leu.2010.154","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T09:42:50Z","timestamp":1281606170000},"page":"1781-1784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["The dual PI3K\/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma"],"prefix":"10.1038","volume":"24","author":[{"given":"P M","family":"Bhende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S I","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D P","family":"Dittmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Damania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,12]]},"reference":[{"key":"BFleu2010154_CR1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC . AKT\/PKB signaling: navigating downstream. Cell 2007; 129: 1261\u20131274.","journal-title":"Cell"},{"key":"BFleu2010154_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/labinvest.3700051","volume":"84","author":"H Zha","year":"2004","unstructured":"Zha H, Raffeld M, Charboneau L, Pittaluga S, Kwak LW, Petricoin III E et al. Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab Invest 2004; 84: 235\u2013244.","journal-title":"Lab Invest"},{"key":"BFleu2010154_CR3","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.1158\/1078-0432.CCR-05-0637","volume":"11","author":"C Gulmann","year":"2005","unstructured":"Gulmann C, Espina V, Petricoin III E, Longo DL, Santi M, Knutsen T et al. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin Cancer Res 2005; 11: 5847\u20135855.","journal-title":"Clin Cancer Res"},{"key":"BFleu2010154_CR4","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1158\/1535-7163.MCT-08-0268","volume":"7","author":"S Ackler","year":"2008","unstructured":"Ackler S, Xiao Y, Mitten MJ, Foster K, Oleksijew A, Refici M et al. ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo. Mol Cancer Ther 2008; 7: 3265\u20133274.","journal-title":"Mol Cancer Ther"},{"key":"BFleu2010154_CR5","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1182\/blood-2006-05-026203","volume":"108","author":"L Leseux","year":"2006","unstructured":"Leseux L, Hamdi SM, Al Saati T, Capilla F, Recher C, Laurent G et al. Syk-dependent mTOR activation in follicular lymphoma cells. Blood 2006; 108: 4156\u20134162.","journal-title":"Blood"},{"key":"BFleu2010154_CR6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ncb1183","volume":"6","author":"E Jacinto","year":"2004","unstructured":"Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004; 6: 1122\u20131128.","journal-title":"Nat Cell Biol"},{"key":"BFleu2010154_CR7","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1182\/blood-2006-06-028092","volume":"109","author":"SH Sin","year":"2007","unstructured":"Sin SH, Roy D, Wang L, Staudt MR, Fakhari FD, Patel DD et al. Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood 2007; 109: 2165\u20132173.","journal-title":"Blood"},{"key":"BFleu2010154_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2141.2006.06132.x","volume":"134","author":"R Shringarpure","year":"2006","unstructured":"Shringarpure R, Catley L, Bhole D, Burger R, Podar K, Tai YT et al. Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib. Br J Haematol 2006; 134: 145\u2013156.","journal-title":"Br J Haematol"},{"key":"BFleu2010154_CR9","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","volume":"7","author":"SM Maira","year":"2008","unstructured":"Maira SM, Stauffer F, Brueggen J, Furet P, Schnell C, Fritsch C et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther 2008; 7: 1851\u20131863.","journal-title":"Mol Cancer Ther"},{"issue":"Suppl 3","key":"BFleu2010154_CR10","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1053\/j.seminoncol.2009.10.011","volume":"36","author":"JJ Gibbons","year":"2009","unstructured":"Gibbons JJ, Abraham RT, Yu K . Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth. Semin Oncol 2009; 36 (Suppl 3): S3\u2013S17.","journal-title":"Semin Oncol"},{"key":"BFleu2010154_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1073\/pnas.0810956106","volume":"106","author":"A Dubrovska","year":"2009","unstructured":"Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, Garcia-Echeverria C et al. The role of PTEN\/Akt\/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 2009; 106: 268\u2013273.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2010154_CR12","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1073\/pnas.1137463100","volume":"100","author":"KS Elenitoba-Johnson","year":"2003","unstructured":"Elenitoba-Johnson KS, Jenson SD, Abbott RT, Palais RA, Bohling SD, Lin Z et al. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci USA 2003; 100: 7259\u20137264.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2010154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010154","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:37:14Z","timestamp":1648733834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2010154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,12]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["BFleu2010154"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.154","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,12]]},"assertion":[{"value":"12 August 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}